## TECH: Bio-Techne Corporation - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.83 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($56.43)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Fort Washington Investment Advisors Inc. OH Buys 35,165 Shares of Bio-Techne Corp $TECH**
- Source: MarketBeat | 20251231T110830 | Somewhat-Bullish | Relevance: 100%
- Fort Washington Investment Advisors Inc. OH increased its stake in Bio-Techne Corp (NASDAQ:TECH) by 8.0% in the third quarter, acquiring an additional 35,165 shares and now holding 474,320 shares valued at approximately $26.39 million. Institutional ownership of Bio-Techne is significantly high at 98.95%, with other major institutional investors also adjusting their positions. Analysts currently give Bio-Techne a consensus rating of "Moderate Buy" with an average price target of $71.00.

**2. Who Owns Bio-Techne Corporation? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20260101T140837 | Somewhat-Bullish | Relevance: 95%
- This article details the top institutional shareholders of Bio-Techne Corporation (NASDAQ: TECH), highlighting significant holdings by firms like The Vanguard Group and BlackRock. It also examines recent insider trading activities, noting modest sales tied to equity awards. The analysis concludes that Bio-Techne continues to receive strong institutional backing despite some managerial reevaluations.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 3 ($0.43M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-2.7%)
- Blackrock Inc.: 7.6% (-2.3%)
- Morgan Stanley: 4.7% (+10.0%)
- State Street Corpora: 3.7% (-1.8%)
- Wellington Managemen: 3.3% (+349.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +3.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.83 indicates undervaluation relative to growth. Forward P/E 27.5x stretched relative to 10% growth. Balance sheet: strong liquidity (4.2x), low leverage (D/E 0.29). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.3B |
| Beta | 1.46 |
| 52W Range | $46.01 - $79.28 |
| Short Interest | 6.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.83 |
| Forward P/E | 27.5 |
| Current P/E | 30.2 |
| YoY Growth | 10.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.5% to 1.2% (+3.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.8pp (needs >4.0% for momentum thesis). MRS_5 at 1.4% confirms short-term momentum alignment. RSI neutral at 50. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.19% (CS: 57) | Neutral |
| RSI_14 | 50.0 | Neutral |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 0.983x | Below |
| vs SMA200 | 1.081x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $59.65
- **Stop Loss:** $56.43 (5.4% risk)
- **Target:** $66.09 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 447
- **Position Value:** $26,663.55
- **Portfolio %:** 26.66%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-09 (Est: $0.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.42 | $0.42 | -0.4% |
| 2025Q2 | $0.50 | $0.53 | +5.8% |
| 2025Q1 | $0.51 | $0.56 | +10.4% |
| 2024Q4 | $0.39 | $0.42 | +7.8% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*